These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 29881992)

  • 1. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
    Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
    Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
    Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.
    Ebadi M; Montano-Loza AJ
    Dig Liver Dis; 2019 Nov; 51(11):1493-1499. PubMed ID: 31221549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
    Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
    World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.
    Lattanzi B; Nardelli S; Pigliacelli A; Di Cola S; Farcomeni A; D'Ambrosio D; Gioia S; Ginanni Corradini S; Lucidi C; Mennini G; Rossi M; Merli M; Riggio O
    Dig Liver Dis; 2019 Nov; 51(11):1508-1512. PubMed ID: 31601536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis.
    Ebadi M; Tsien C; Bhanji RA; Dunichand-Hoedl AR; Rider E; Motamedrad M; Mazurak VC; Baracos V; Montano-Loza AJ
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?
    Nardelli S; Gioia S; Ridola L; Carlin M; Cioffi AD; Merli M; Spagnoli A; Riggio O
    Dig Liver Dis; 2022 Mar; 54(3):371-377. PubMed ID: 34233863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis.
    Di Cola S; D'Amico G; Caraceni P; Schepis F; Loredana S; Lampertico P; Toniutto P; Martini S; Maimone S; Colecchia A; Svegliati Barone G; Alessandria C; Aghemo A; Crocè SL; Adinolfi LE; Rendina M; Lapenna L; Pompili E; Zaccherini G; Saltini D; Iavarone M; Tosetti G; Martelletti C; Nassisi V; Ferrarese A; Giovo I; Masetti C; Pugliese N; Campigotto M; Nevola R; Merli M;
    J Hepatol; 2024 Oct; 81(4):641-650. PubMed ID: 38782120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
    Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meld-sarcopenia score and skeletal muscle density predicts short-term readmission of patients with hepatic encephalopathy.
    Yang S; Zhang L; Jin Q; Wang J; Ma D; Gao J; Huang R
    Eur J Radiol; 2023 Dec; 169():111178. PubMed ID: 37922620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management.
    Lucero C; Verna EC
    Clin Liver Dis; 2015 Aug; 19(3):507-28. PubMed ID: 26195205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between imaging-based body composition abnormalities and long-term mortality in patients with liver cirrhosis.
    Ren W; Zheng J; Yang S; Zhong J; Liu X; Liu X; Feng J; Wei T; Yang Y; Tie C; Hong C; Feng B; Huang R
    Eur J Radiol; 2024 Nov; 180():111707. PubMed ID: 39197272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis.
    Chang KV; Chen JD; Wu WT; Huang KC; Lin HY; Han DS
    J Formos Med Assoc; 2019 Apr; 118(4):833-842. PubMed ID: 30279030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosteatosis is an independent risk factor for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunting.
    Shi W; Yin H; Yu Z; Li Y; Bai X; Fu S; Duan C; Xu W; Yang Y
    Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):897-903. PubMed ID: 38477843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
    Findlay M; White K; Brown C; Bauer JD
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China.
    Zeng X; Shi ZW; Yu JJ; Wang LF; Sun CY; Luo YY; Shi PM; Lin Y; Chen YX; Guo J; Zhang CQ; Xie WF
    Hepatol Int; 2024 Apr; 18(2):673-687. PubMed ID: 37332023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts.
    Nardelli S; Riggio O; Gioia S; Merli M; Spagnoli A; di Martino M; Pelle G; Ridola L
    Dig Liver Dis; 2022 Aug; 54(8):1060-1065. PubMed ID: 35058135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed-Tomography Body Composition Analysis Complements Pre-Operative Nutrition Screening in Colorectal Cancer Patients on an Enhanced Recovery after Surgery Pathway.
    Klassen P; Baracos V; Gramlich L; Nelson G; Mazurak V; Martin L
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33291416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.
    Gioia S; Merli M; Nardelli S; Lattanzi B; Pitocchi F; Ridola L; Riggio O
    Liver Int; 2019 May; 39(5):871-877. PubMed ID: 30667572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.